Virus News and Research

Latest Virus News and Research

African countries should step up surveillance and border controls for bird flu

The highly pathogenic avian influenza virus often spreads through the movement of affected birds, FAO/World Organisation for Animal Health (OIE) said.

13 Feb 2006

Researchers unmask secrets of a tiny virus that infects bacteria

Using powerful computer tools and cryo-electron microscopes, researchers at Baylor College of Medicine unmasked the secrets of a tiny virus that infects bacteria and, in doing so, opened the door to a better understanding of a variety of viruses that infect people and animals.

13 Feb 2006

Lamivudine helps avoid Hepatitis B relapse during chemotherapy

A new study on treating hepatitis B patients who have cancer with an antiviral drug at the same time as they undergo chemotherapy found that the treatment helped prevent relapse of hepatitis B.

12 Feb 2006

National childhood flu-vaccine programs should include evaluation component

If the United States were to launch an annual influenza-vaccination program among the nation's school children, resources also should go to evaluate the program's success in reducing community-wide flu transmission, according to a "Policy Forum" editorial in Science authored by researchers based at Fred Hutchinson Cancer Research Center.

12 Feb 2006

Bird flu found in wild birds in Greece, Italy and Bulgaria

According to European officials, the deadly H5N1 bird flu virus has been found in wild birds in Italy and Greece, and in Bulgaria.

12 Feb 2006

Viruses can be forced to evolve in ways to benefit humans

Viruses and humans have evolved together over millions of years in a game of one-upmanship that, often as not, left humans sick or worse.

7 Feb 2006

Discovery of the molecular mechanism that inhibits HCV replication in vitro

Since its discovery several decades ago, the insidious human pathogen has stymied the quest for anti-viral therapies by refusing to reproduce in test tubes for more than a few hours or days, denying scientists an efficient virus production and infection system for experimental research.

7 Feb 2006

New technology for accelerating development of vaccines against H5N1 flu

Technology that enables scientists to identify targets for the development of vaccines against viruses such as H5N1 in weeks rather than months has entered a pilot study at ProImmune, Oxford, UK.

7 Feb 2006

FDA grants fast track status for ViroPharma's Maribavir

ViroPharma Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for maribavir, an oral antiviral drug candidate for the prevention of cytomegalovirus (CMV) infection in allogeneic bone marrow (stem cell) and solid organ transplant patients.

7 Feb 2006

Viragen reports on Multiferon anti-viral studies

Viragen, Inc today reported on the progression of anti-viral studies using Multiferon (multi-subtype, natural human alpha interferon) being conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

7 Feb 2006

HIV subtype is a better predictor than viral load for determining rapid death from AIDS

Traditional testing standards help monitor the progression of an HIV infection to AIDS by keeping track of viral load, using a scale in which less than 50 viral particles per cubic milliliter of blood is considered suppressed disease and a viral load of more than 75,000 particles per cubic milliliter of blood means that the disease will progress more rapidly.

7 Feb 2006

Call for public health intervention to treat young injection drug users infected with the hepatitis C virus

In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV).

7 Feb 2006

Rotavirus vaccine will protect children against a major killer worldwide

The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.

7 Feb 2006

Hepatitis C recurs rapidly after liver transplant

When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy liver transplant, virus levels rebound and can surpass pre-transplant levels within a few days, according to a new study published in the February 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).

2 Feb 2006